Jump to navigation Jump to search
Clinical data
ATC code
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass181.232 g/mol

WikiDoc Resources for Etilefrine


Most recent articles on Etilefrine

Most cited articles on Etilefrine

Review articles on Etilefrine

Articles on Etilefrine in N Eng J Med, Lancet, BMJ


Powerpoint slides on Etilefrine

Images of Etilefrine

Photos of Etilefrine

Podcasts & MP3s on Etilefrine

Videos on Etilefrine

Evidence Based Medicine

Cochrane Collaboration on Etilefrine

Bandolier on Etilefrine

TRIP on Etilefrine

Clinical Trials

Ongoing Trials on Etilefrine at Clinical

Trial results on Etilefrine

Clinical Trials on Etilefrine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Etilefrine

NICE Guidance on Etilefrine


FDA on Etilefrine

CDC on Etilefrine


Books on Etilefrine


Etilefrine in the news

Be alerted to news on Etilefrine

News trends on Etilefrine


Blogs on Etilefrine


Definitions of Etilefrine

Patient Resources / Community

Patient resources on Etilefrine

Discussion groups on Etilefrine

Patient Handouts on Etilefrine

Directions to Hospitals Treating Etilefrine

Risk calculators and risk factors for Etilefrine

Healthcare Provider Resources

Symptoms of Etilefrine

Causes & Risk Factors for Etilefrine

Diagnostic studies for Etilefrine

Treatment of Etilefrine

Continuing Medical Education (CME)

CME Programs on Etilefrine


Etilefrine en Espanol

Etilefrine en Francais


Etilefrine in the Marketplace

Patents on Etilefrine

Experimental / Informatics

List of terms related to Etilefrine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Etilefrine is a cardiac stimulant used as an antihypotensive. It is a sympathomimetic amine of the 3-hydroxy-phenylethanolamine series used in treating orthostatic hypotension of neurological, cardiovascular, endocrine or metabolic origin. Intravenous infusion of this compound increases cardiac output, stroke volume, venous return and blood pressure in man and experimental animals, suggesting stimulation of both α and β adrenergic receptors.[1] However, in vitro studies indicate that etilefrine has a much higher affinity for β1 (cardiac) than for β2 adrenoreceptors.[2]

Intravenous etilefrine increases the pulse rate, cardiac output, stroke volume, central venous pressure and mean arterial pressure of healthy individuals. Peripheral vascular resistance falls during the infusion of 1–8 mg etilefrine but begins to rise at higher dosage. Marked falls in pulse rate, cardiac output, stroke volume and peripheral bloodflow, accompanied by rises in mean arterial pressure, occur when etilefrine is infused after administration of intravenous propranolol 2,5 mg. These findings indicate that etilefrine has both β1 and α1 adrenergic effects in man.


  1. Nusser, Donath and Russ, 1965; Mellander, 1966; Limbourg, Just and Lang, 1973; Tarnow et al.~1973; Carrera and Aguilera, 1973.
  2. Offermeier and Dreyer, 1971.

Template:Cardiac stimulants excluding cardiac glycosides